The Discounted Cash Flow (DCF) valuation of Santhera Pharmaceuticals Holding AG (SANN.SW) is 154.36 CHF. With the latest stock price at 9.25 CHF, the upside of Santhera Pharmaceuticals Holding AG based on DCF is 1568.8%.
| Range | Selected | |
| WACC / Discount Rate | 4.3% - 7.7% | 6.0% |
| Long-term Growth Rate | 0.0% - 1.0% | 0.5% |
| Fair Price | 110.81 - 256.75 | 154.36 |
| Upside | 1098.0% - 2675.7% | 1568.8% |